Text Size
92 studies found for:    "Hemophilia B"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B
Condition: Hemophilia B
Intervention: Drug: Recombinant Factor IX Coagulation
2 Completed
Has Results 		Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B
Condition: Hemophilia B
Intervention: Drug: Recombinant Coagulation Factor IX (BeneFIX)
3 Active, not recruiting Gene Transfer for Subjects With Hemophilia B Factor IX Deficiency
Condition: Hemophilia B
Intervention: Biological: AAV2-hFIX
4 Completed Study Evaluating rFIX; BeneFIX in Severe Hemophilia B
Condition: Hemophilia B
Intervention: Drug: BeneFIX
5 Completed Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia B
Condition: Hemophilia B
Intervention: Drug: BeneFIX (coagulation factor IX (recombinant))
6 Completed Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use
Condition: Hemophilia B
Intervention:
7 Completed Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients
Condition: Hemophilia B
Interventions: Drug: blood draw;   Procedure: Blood draw
8 Recruiting Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B
Condition: Hemophilia B
Intervention: Biological: AskBio009
9 Completed Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)
Condition: Hemophilia B
Intervention: Drug: human coagulation Factor IX
10 Active, not recruiting Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B
Condition: Hemophilia B
Intervention: Biological: Nonacog alfa
11 Completed Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B
Conditions: Hemophilia B;   Allergic Reactions
Intervention:
12 Recruiting Hemophilia B Gene Therapy - CCMT at CHOP
Condition: Hemophilia B
Intervention: Biological: AAV8-hFIX19
13 Terminated Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B
Condition: Hemophilia B
Intervention: Genetic: Adeno-Associated Viral with Human Factor IX
14 Completed Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B
Condition: Hemophilia B
Interventions: Drug: rFIX;   Drug: rFIX-R
15 Active, not recruiting Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B
Condition: Hemophilia B
Intervention: Drug: Recombinant factor IX Product, IB1001
16 Enrolling by invitation Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Condition: Severe Hemophilia B
Intervention: Biological: rFIXFc
17 Completed Study Evaluating rFIX; BeneFIX® in Hemophilia B
Condition: Hemophilia B
Intervention: Drug: rFIX
18 Completed
Has Results 		Study Evaluating On-Demand Treatment With BeneFIX In Chinese Subjects
Condition: Hemophilia B
Intervention: Biological: Benefix
19 Active, not recruiting Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B
Condition: Hemophilia B
Interventions: Biological: IB1001 (On-Demand);   Biological: IB1001 (Prophylaxis)
20 Completed A Safety and Efficacy Study of a Recombinant Factor IX in Patients With Severe Hemophilia B
Condition: Hemophilia B
Intervention: Biological: Recombinant Coagulation Factor IX Albumin Fusion Protein
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years